14:42:20 EDT Tue 27 Oct 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Shell Summary for May 15, 2020

2020-05-15 20:34 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange climbed 10.75 points to 509.01 Friday, ending the week up 16.92 points. Mick Thomson's 10th capital pool shell, Panorama Capital Corp. (PANO: halted), plans to acquire a U.S. medical device company called Avisa Pharma Inc. for the shell's qualifying transaction. The shell will roll back 1 for 3, leaving it with 2,933,333 shares issued, then issue 46,865,040 shares to its target's shareholders.

Avisa was founded in Santa Fe, N.M., in 2010. It holds a licence to commercialize a diagnostic breath test that was developed by the University of New Mexico. The company is working on a device called the Avisa BreathTest, which is designed to detect pneumonia and other pulmonary infections or respiratory diseases within 10 minutes. (The company does not mention COVID-19 or any other coronavirus.) Avisa notes that existing respiratory diagnostic tests, which analyze mucous samples rather than breath samples, can take up to three days.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.